Tag: Godavari Biorefineries
Godavari Biorefineries secures Japanese patent for antiviral compounds targeting viral infections
The patent protects antiviral compounds developed by the company that inhibit Vacuolar ATPase (V-ATPase) activity in cells, a mechanism involved in viral infection pathways
Godavari Biorefineries addresses bioeconomy transition at Bio Innovations APAC 2026
The conference convened stakeholders from across the Asia-Pacific industrial biomanufacturing ecosystem and included targeted one-to-one meetings to facilitate collaborations and partnerships
Godavari Biorefineries partners Synthomer to develop bio-based alternatives to fossil-based monomers
Through this partnership, Synthomer is commercialising bio-based butyl acrylate using bio-based butanol produced by GBL, helping to accelerate the industry’s transition to more sustainable raw materials
GBL Executive Director Dr Sangeeta Srivastava conferred honorary fellow title by...
The honour was presented during the opening session of the XXII BRSI Convention, hosted alongside the International Conference on Advances in Biotechnology, Bioprocessing and Structural Biology (ICABSB-2025) at IIT Roorkee
Godavari Biorefineries and ICT Mumbai launch CO₂-to-DME Technology Pilot Project
The technology, developed in collaboration with the Institute of Chemical Technology, Mumbai (ICT), demonstrates how scientific innovation can directly address the global challenge of greenhouse gas reduction while generating economic value from industrial waste
Godavari Biorefineries secures Chinese patent for its breakthrough anti-cancer molecule
These compounds have demonstrated significant efficacy against multiple cancer cell types, including breast and prostate cancer
Godavari Biorefineries’ anti-cancer patent secures key European validations
Anti-cancer patent now validated in Spain, the UK, and as a unitary patent covering multiple EU member states
Godavari Biorefineries achieves 12% YoY revenue growth in Q3 FY25
Revenue from operations rose to ₹447.3 crore, up from ₹398.0 crore in Q3 FY24, with an EBITDA of ₹39.7 crore and a Profit After Tax (PAT) of ₹5.8 crore.
Godavari Biorefineries invests in a new corn & grain-based distillery to...
Strategic Investment of approximately ₹130 Crore to Boost Ethanol Capacity with Dual-Feedstock Flexibility, Aligning with India’s Green Energy Goals
Godavari Biorefineries secures exclusive license agreement with Catalyxx Inc for Biobutanol
Pioneering partnership sets the stage for sustainable innovation in the chemical industry through Catalyxx’s bio-based chemicals technology